Publications by authors named "Matthias A Karajannis"

Claim this Profile
A
Advancing CNS tumor diagnostics with expanded DNA methylation-based classification.
Martin Sill, Daniel Schrimpf, Areeba Patel, Dominik Sturm, Natalie Jäger, Matthias A Karajannis

Cancer Cell· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diffuse midline glioma with extra central nervous system metastases in the pediatric, adolescent, and young adult population.
Alexandra M Giantini-Larsen, Andrew L A Garton, Maricruz Rivera, Rachael Han, David J Pisapia, Matthias A Karajannis

Childs Nerv Syst· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
FOXR2 activation is not exclusive of CNS neuroblastoma.
Alexa N Siskar, Emily Hanzlik, Maria F Cardenas, Mohammad K Eldomery, Soniya Pinto, Matthias A Karajannis

Neuro Oncol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Financial toxicity in pediatric and adolescent neurosurgical oncology.
Alexandra M Giantini-Larsen, Samantha Brown, Anne S Reiner, Stephanie Doyle Giandalone, Kyle Zappi, Matthias A Karajannis

J Neurooncol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prospective characterization of germline variants in patients with gliomas and glioneuronal tumors.
Subhiksha Nandakumar, Miika Mehine, Yelena Kemel, Chaitanya Bandlamudi, Diana Mandelker, Matthias A Karajannis

Acta Neuropathol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improving Global Access to Genomic Profiling in Rare Pediatric Cancers.
Sameer Farouk Sait, Tara J O'Donohue, Tejus Bale, Anita Bowman, Katherine Hill, Matthias A Karajannis

Clin Cancer Res· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of bevacizumab on non-target intracranial meningiomas and non-vestibular schwannomas in NF2-related schwannomatosis: NF104.
Vihang Nakhate, Ina Ly, Alona Muzikansky, Otto Rapalino, Jeffrey C Allen, Matthias A Karajannis

J Neurooncol· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A population-based analysis of the molecular landscape of glioma in adolescents and young adults reveals insights into gliomagenesis.
Julie Bennett, Adrian B Levine, Liana Nobre, Logine Negm, Jiil Chung, Matthias A Karajannis

Nat Cancer· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase 2 trial of veliparib, local irradiation, and temozolomide in patients with newly diagnosed high-grade glioma: a Children's Oncology Group study.
Matthias A Karajannis, Arzu Onar-Thomas, Tong Lin, Patricia A Baxter, Daniel R Boué

Neuro Oncol· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Advancing CNS tumor diagnostics with expanded DNA methylation-based classification.
Martin Sill, Daniel Schrimpf, Areeba Patel, Dominik Sturm, Natalie Jäger, Matthias A Karajannis

medRxiv· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase II study of axitinib in patients with -related schwannomatosis and progressive vestibular schwannomas.
Mekka R Garcia, Mari Hagiwara, Anna Yaffe, Carole Mitchell, Srivandana Akshintala, Matthias A Karajannis

Neurooncol Adv· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A multi-institutional retrospective cohort of adult-onset medulloblastoma in the modern era.
Alipi V Bonm, Michael S Rutenberg, Kate E Therkelsen, John Herbst, Anurag Sanaf, Matthias A Karajannis

Neurooncol Adv· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Selective nitration of Hsp90 acts as a metabolic switch promoting tumor cell proliferation.
Isabelle E Logan, Kyle T Nguyen, Tilottama Chatterjee, Bhagyashree Manivannan, Ngozi P Paul, Matthias A Karajannis

Redox Biol· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hypofractionated re-irradiation for diffuse intrinsic pontine glioma.
Nikhil P Mankuzhy, Kathryn R Tringale, Ira J Dunkel, Sameer Farouk Sait, Mark M Souweidane, Matthias A Karajannis

Pediatr Blood Cancer· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical outcome of pediatric medulloblastoma patients with Li-Fraumeni syndrome.
Anna S Kolodziejczak, Lea Guerrini-Rousseau, Julien Masliah Planchon, Jonas Ecker, Florian Selt, Matthias A Karajannis

Neuro Oncol· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cotargeting Phosphoinositide 3-Kinase and Focal Adhesion Kinase Pathways Inhibits Proliferation of NF2 Schwannoma Cells.
Haley M Hardin, Christine T Dinh, Julianne Huegel, Alejandra M Petrilli, Olena Bracho, Matthias A Karajannis

Mol Cancer Ther· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recurrent TRAK1::RAF1 Fusions in pediatric low-grade gliomas.
Jamal K Benhamida, Hannah J Harmsen, Deqin Ma, Christopher M William, Bryan K Li, Matthias A Karajannis

Brain Pathol· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multicenter, prospective, phase II study of maintenance bevacizumab for children and adults with NF2-related schwannomatosis and progressive vestibular schwannoma.
Scott R Plotkin, Jeffrey Allen, Girish Dhall, Jian L Campian, D Wade Clapp, Matthias A Karajannis

Neuro Oncol· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cerebrospinal fluid: The new frontier for methylome-based diagnostic classification of brain tumors.
Alexandra M Miller, Matthias A Karajannis

Neuro Oncol· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical utility of whole-genome DNA methylation profiling as a primary molecular diagnostic assay for central nervous system tumors-A prospective study and guidelines for clinical testing.
Kristyn Galbraith, Varshini Vasudevaraja, Jonathan Serrano, Guomiao Shen, Ivy Tran, Matthias A Karajannis

Neurooncol Adv· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Slipped capital femoral epiphyses: A major on-target adverse event associated with FGFR tyrosine kinase inhibitors in pediatric patients.
Sameer Farouk Sait, Cheryl Fischer, Zoltan Antal, Krisoula Spatz, Daniel E Prince, Matthias A Karajannis

Pediatr Blood Cancer· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Leptomeningeal disease in histone-mutant gliomas.
Maria Diaz, Satshil Rana, Carlos Eduardo Silva Correia, Anne S Reiner, Andrew L Lin, Matthias A Karajannis

Neurooncol Adv· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment of Pediatric Low-Grade Gliomas.
Sameer Farouk Sait, Alexandra M Giantini-Larsen, Kathryn R Tringale, Mark M Souweidane, Matthias A Karajannis

Curr Neurol Neurosci Rep· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase II study of everolimus for recurrent or progressive pediatric ependymoma.
Daniel C Bowers, Veena Rajaram, Matthias A Karajannis, Sharon L Gardner, Jack Meng-Fen Su

Neurooncol Adv· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Current Role and Future Potential of CSF ctDNA for the Diagnosis and Clinical Management of Pediatric Central Nervous System Tumors.
Alexandra M Miller, Matthias A Karajannis

J Natl Compr Canc Netw· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis